Hepatitis B Virus Infection Pipeline Insight Report 2024: Therapeutic Assessment of 80+ Companies and 90+ Drugs
August 13, 2024 10:34 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Virus Infection - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Hepatitis B Virus...
Tinea Pedis (Athlete`s Foot) Treatment Global Report 2024: Market to Grow by $300 Million by 2030 - Emergence of New Antifungal Agents Boosts Innovation
July 31, 2024 04:36 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Tinea Pedis (Athlete`s Foot) Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Staphylococcal Infections Therapeutics Report 2024: Comprehensive Insights about 22+ Companies and 23+ Pipeline Drugs
July 29, 2024 09:45 ET
|
Research and Markets
Dublin, July 29, 2024 (GLOBE NEWSWIRE) -- The "Staphylococcal Infections - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Staphylococcal Infections...
Hepatitis A Therapeutics Market Research 2024: Comprehensive Insights about 3+ Companies and 3+ Pipeline Drugs Featuring Boryung Pharma, Cadila Healthcare, Indian Immunologicals, & Biological E
July 25, 2024 07:47 ET
|
Research and Markets
Dublin, July 25, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis A - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Hepatitis A - Pipeline Insight, 2024,"...
Hepatitis D Therapeutics Market Research 2024: Comprehensive Insights about 6+ Companies and 6+ Pipeline Drugs
July 23, 2024 09:53 ET
|
Research and Markets
Dublin, July 23, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis D - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
$230+ Bn Anti-Infectives Markets - Global Strategic Business Report to 2030: Telemedicine and Digital Health Platforms Drives Adoption, Rising Prevalence of Drug-Resistant Infections Spurs Innovation
July 22, 2024 09:15 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Infectives - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Anti-Infectives...
$6.6 Bn Herpes Simplex Virus Infections Markets - Global Strategic Business Report to 2030 with Coverage of 10+ Major Players Including Admedus, Agenus, and Aicuris Anti-infective Cures
July 19, 2024 08:50 ET
|
Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "Herpes Simplex Virus Infections - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Chagas Disease Therapeutic Assessment 2024: Comprehensive Insights About 5+ Companies and 5+ Pipeline Drugs
July 17, 2024 10:10 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Chagas disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Cytomegalovirus Infection Therapeutics Research 2024: Comprehensive Insights About 15+ Companies and 20+ Pipeline Drugs Featuring Vir, SpyBiotech, Moderna, VBI, Trellis Bioscience, GSK, & AlloVir
July 03, 2024 04:10 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Cytomegalovirus Infection - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Cytomegalovirus...
Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review 2024: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
July 01, 2024 09:52 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...